Patents Assigned to Anticancer Therapeutic Inventions AS
  • Receptor binding conjugates
    Patent number: 6740304
    Abstract: The present invention relates to a receptor binding conjugate which consists of an antibody, a radionuclide and folate or a folate derivative, wherein or not the conjugate possesses dual binding ability. The present invention also relates to a method and a kit to prepare, as well as a method to use, such conjugates. Furthermore, the use of a conjugate according to the present invention to prepare a pharmaceutical solution is disclosed.
    Type: Grant
    Filed: December 5, 2000
    Date of Patent: May 25, 2004
    Assignee: Anticancer Therapeutic Inventions AS
    Inventors: Roy H. Larsen, Gjermund Henriksen
  • Preparation and use of radium-223 to target calcified tissues for pain palliation, bone cancer therapy, and bone surface conditioning
    Patent number: 6635234
    Abstract: Processes for the preparation, prepared solutions, and the use of radium-223 for the treatment of calcified tumors, bone tumors, treatment of bones, bone surfaces and soft tissues is described.
    Type: Grant
    Filed: January 3, 2000
    Date of Patent: October 21, 2003
    Assignee: Anticancer Therapeutic Inventions AS
    Inventors: Roy H. Larsen, Gjermund Henriksen, Øyvind S. Bruland
  • Radioactive therapeutic liposomes
    Patent number: 6592843
    Abstract: The present invention relates to a conjugator system comprising liposomes with ionophores, and with chelator solution and alpha-particle emitting radionuclide(s) located inside of the liposome. Furthermore, a the method for the preparation of this type of radioactive liposomes is described, as well as use of the system and a kit for preparing the system.
    Type: Grant
    Filed: February 21, 2001
    Date of Patent: July 15, 2003
    Assignee: Anticancer Therapeutic Inventions AS
    Inventors: Roy H. Larsen, Gjermund Henriksen